Next Science | Investor Centre

Next Science Limited (ASX: NXS) is a medical technology company headquartered in Sydney, Australia, with commercial operations in Florida, USA. Next Science’s primary focus is the development and continued commercialisation of its proprietary XBIO™ technology to reduce the impact of biofilm-based infections in human health.

Join the Next Science Investor Hub to interact with our announcements and updates, have your questions answered, and receive ASX Announcements and Company Updates to your inbox. Click here to sign up to the Next Science Investor Hub.

Half Year & Full Year Reports

Period Ending	Report	Webcast	Results Release
2023 Half Year Results	Opens in new window		Opens in new window
2022 Half Year Results	Opens in new window
2021 Full Year Results	Opens in new window		Opens in new window
2021 Half Year Results	Opens in new window
2021 Annual Report	Opens in new window
2020 Annual Report	Opens in new window
2020 Full Year Results	Opens in new window	Opens in new window	Opens in new window
2020 Half Year Results	Opens in new window	Opens in new window	Opens in new window

Investor contacts

Investor queries

Next Science Limited
Level 19, Tower A, The Zenith
821 Pacific Highway, Chatswood
NSW 2067
Ph: +61 2 8607 5124
E: [email protected]

Share Registry queries

Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Ph: 1300 554 474